S06613 Summary:

BILL NOS06613
 
SAME ASSAME AS A02114-A
 
SPONSORFERNANDEZ
 
COSPNSROBERACKER, HOYLMAN-SIGAL, MAY
 
MLTSPNSR
 
Add 921-b, Ed L
 
Authorizes schools to possess and administer FDA approved opioid reversal agents in emergency situations to negate or neutralize, in whole or in part, the pharmacological effects of an opioid in the human body.
Go to top    

S06613 Actions:

BILL NOS06613
 
05/01/2023REFERRED TO EDUCATION
01/03/2024REFERRED TO EDUCATION
Go to top

S06613 Committee Votes:

Go to top

S06613 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S06613 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          6613
 
                               2023-2024 Regular Sessions
 
                    IN SENATE
 
                                       May 1, 2023
                                       ___________
 
        Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when
          printed to be committed to the Committee on Education
 
        AN ACT to amend the education law, in relation to authorizing schools to
          possess and administer FDA approved opioid reversal agents in emergen-
          cy situations

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. The education law is amended by adding a new section  921-b
     2  to read as follows:
     3    §  921-b.  On-site  FDA  approved  opioid reversal agents.   1. School
     4  districts, boards of cooperative educational services, county vocational
     5  education and extension boards, charter schools, and non-public  elemen-
     6  tary  and  secondary  schools  in  this  state  may provide and maintain
     7  on-site in each instructional school facility all  FDA  approved  opioid
     8  reversal  agents  in quantities and types deemed by the commissioner, in
     9  consultation with the commissioner of health, to be adequate  to  ensure
    10  ready  and  appropriate access for use during emergencies to any student
    11  or staff to negate or neutralize, in whole or in part, the pharmacologi-
    12  cal effects of an opioid in the human body.
    13    2. School districts, boards of cooperative educational services, coun-
    14  ty vocational education and extension boards, charter schools, and  non-
    15  public  elementary  and  secondary  schools  in  this  state, any person
    16  employed by any such entity, or employed by  a  contractor  of  such  an
    17  entity  while  performing services for the entity may administer any FDA
    18  approved opioid reversal agents in the event of an emergency.
    19    § 2. This act shall take effect on the one hundred twentieth day after
    20  it shall have become a law. Effective immediately, the addition,  amend-
    21  ment and/or repeal of any rule or regulation necessary for the implemen-
    22  tation  of  this act on its effective date are authorized to be made and
    23  completed on or before such effective date.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02445-03-3
Go to top